Drug Approval | April 14, 2025
Aurobindo receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
The product will be launched in Q1FY26
The product will be launched in Q1FY26
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
Strengthening capabilities in Peptide Therapeutics and CDMO services
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
The IND application supports the next phase of development of SBO-154
Subscribe To Our Newsletter & Stay Updated
